Rituximab versus cyclophosphamide for ANCA-associated vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera, Philip Seo, Carol A. Langford, Gary S. Hoffman, Cees G.M. Kallenberg, E. William St Clair, Anthony Turkiewicz, Nadia K. Tchao, Lisa Webber, Linna Ding, Lourdes P. Sejismundo, Kathleen Mieras, David Weitzenkamp, David Ikle, Vicki Seyfert-Margolis, Mark Mueller, Paul Brunetta, Nancy B. AllenFernando C. Fervenza, Duvuru Geetha, Karina A. Keogh, Eugene Y. Kissin, Paul A. Monach, Tobias Peikert, Coen Stegeman, Steven R. Ytterberg, Ulrich Specks

Research output: Contribution to journal › Article › peer-review

1558 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab versus cyclophosphamide for ANCA-associated vasculitis'. Together they form a unique fingerprint.

Medicine & Life Sciences